Rosiglitazone, insulin treatment, and fasting correct defective activationof protein kinase C-zeta/lambda by insulin in vastus lateralis muscles andadipocytes of diabetic rats
Y. Kanoh et al., Rosiglitazone, insulin treatment, and fasting correct defective activationof protein kinase C-zeta/lambda by insulin in vastus lateralis muscles andadipocytes of diabetic rats, ENDOCRINOL, 142(4), 2001, pp. 1595-1605
Atypical protein kinases C (PKCs), sigma and lambda, and protein kinase B(P
KB) are thought to function downstream of phosphatidylinositol 8-kinase (PI
3-kinase) and regulate glucose transport during insulin action in skeletal
muscle and adipocytes. Insulin-stimulated glucose transport is defective i
n type II diabetes mellitus, and this defect is ameliorated by thiazolidine
diones and lowering of blood glucose by chronic insulin therapy or short-te
rm fasting. Presently, we evaluated the effects of these insulin-sensitizin
g modalities on the activation of insulin receptor substrate-1 (IRS-1)-depe
ndent PI 3-kinase, PKC-sigma/lambda, and PKB in vastus lateralis skeletal m
uscles and adipocytes of nondiabetic and Goto-Kakizaki (GK) diabetic rats.
Insulin provoked rapid increases in the activity of PI 3-kinase, PKC-sigma/
lambda, and PKB in muscles and adipocytes of nondiabetic rats, but increase
s in IRS-l-dependent PI 3-kinase and PKC-sigma/lambda, but not PKB, activit
y were substantially diminished in GK muscles and adipocytes. Rosiglitazone
treatment for 10-14 days, 10-day insulin treatment, and 60-h fasting rever
sed defects in PKC-Uh activation in GK muscles and adipocytes and increased
glucose transport in GK adipocytes, without necessarily increasing IRS-1-d
ependent PI 8-kinase or PKB activation. Our findings suggest that insulin-s
ensitizing modalities, viz. thiazolidinediones, chronic insulin treatment,
and short-term fasting, similarly improve defects in insulin-stimulated glu
cose transport at least partly by correcting defects in insulin-induced act
ivation of PKC-sigma/lambda.